InvestorsObserver
×
News Home

Is CEL-SCI Corporation (CVM) Stock at the Top of the Biotechnology Industry?

Monday, November 27, 2023 12:29 PM | InvestorsObserver Analysts

Mentioned in this article

Is CEL-SCI Corporation (CVM) Stock at the Top of the Biotechnology Industry?

CEL-SCI Corporation (CVM) is near the top in its industry group according to InvestorsObserver. CVM gets an overall rating of 81. That means it scores higher than 81 percent of stocks. CEL-SCI Corporation gets a 97 rank in the Biotechnology industry. Biotechnology is number 53 out of 148 industries.

Overall Score - 81
CVM has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on CVM!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 81 means the stock is more attractive than 81 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With CEL-SCI Corporation Stock Today?

CEL-SCI Corporation (CVM) stock has risen 5.95% while the S&P 500 has fallen -0.1% as of 12:16 PM on Monday, Nov 27. CVM has risen $0.15 from the previous closing price of $2.52 on volume of 423,403 shares. Over the past year the S&P 500 has gained 14.90% while CVM has fallen -9.18%. CVM lost -$0.78 per share the over the last 12 months. Click Here to get the full Stock Report for CEL-SCI Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App